Specification
| Product Details | |
| Generic Name | Gilteritinib |
| Strength | 40mg |
| Medicine Form | Tablets |
| Manufactured By | Everest Pharma |
| Quantity | 90 Tablets |
| Packaging Type | Bottle |
Gilternib (Gilteritinib 40 mg Tablets) is a potent, selective inhibitor of FLT3, a receptor tyrosine kinase frequently mutated in acute myeloid leukemia (AML). It is specifically indicated for the treatment of adult patients with relapsed or refractory AML with a FLT3 mutation, as detected by an FDA-approved test. By inhibiting the FLT3 protein, Gilteritinib helps to prevent the growth and spread of cancer cells. Our super specialty pharmacy provides high-quality Gilternib with personalized treatment plans and expert support to ensure optimal care for AML patients. Trust us for comprehensive and effective cancer care tailored to your specific needs.
